Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Yves Cahn

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Blood Advances|June 16, 2019
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remissionArmin Rashidi, Mehdi Hamadani, Mei-Jie Zhang, et al.
Blood Advances|October 4, 2023
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysisHemant S Murthy, Mei-Jie Zhang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant CyclophosphamideAnnie Im, Armin Rashidi, Tao Wang, et al.
Blood Advances|September 21, 2021
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemiaMatthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, et al.
Blood Advances|July 15, 2020
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR reportZheng Zhou, Rajneesh Nath, Jan Cerny, et al.
Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Blood Advances|June 16, 2019
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remissionArmin Rashidi, Mehdi Hamadani, Mei-Jie Zhang, et al.
Blood Advances|October 4, 2023
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysisHemant S Murthy, Mei-Jie Zhang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant CyclophosphamideAnnie Im, Armin Rashidi, Tao Wang, et al.
Blood Advances|September 21, 2021
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemiaMatthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, et al.
Blood Advances|July 15, 2020
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR reportZheng Zhou, Rajneesh Nath, Jan Cerny, et al.
Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 17